home / stock / plx / plx news


PLX News and Press, Protalix BioTherapeutics Inc. From 08/07/25

Stock Information

Company Name: Protalix BioTherapeutics Inc.
Stock Symbol: PLX
Market: NYSE
Website: protalix.com

Menu

PLX PLX Quote PLX Short PLX News PLX Articles PLX Message Board
Get PLX Alerts

News, Short Squeeze, Breakout and More Instantly...

PLX - Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025

Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025 PR Newswire Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , Aug. 7, 2025 /PRNewswire/ -- Protalix BioTherapeutics...

PLX - Protalix BioTherapeutics appoints Gilad Mamlok as CFO

2025-07-21 07:00:39 ET More on Protalix BioTherapeutics Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025 Protalix BioTherapeutics Q1 Earnings Preview Seeking Alpha...

PLX - Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer

Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer PR Newswire CARMIEL, Israel , July 21, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focu...

PLX - Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®

Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes® PR Newswire CARMIEL, Israel , June 30, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production an...

PLX - Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC PR Newswire CARMIEL, Israel , May 14, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company foc...

PLX - Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025

2025-05-09 16:13:20 ET More on Protalix BioTherapeutics Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earni...

PLX - Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript

2025-05-09 16:12:51 ET Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Mike Moyer – Investor Relations Dror Bashan – President and Chief Executive Officer Eyal Rubin – Senior V...

PLX - Protalix BioTherapeutics GAAP EPS of -$0.05 misses by $0.13, revenue of $10.11M misses by $11.49M

2025-05-09 06:56:32 ET More on Protalix BioTherapeutics Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript Protalix BioTherapeutics Q1 Earnings Preview ...

PLX - Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results

Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results PR Newswire Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , May 9, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Americ...

PLX - Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025

Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025 PR Newswire Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , May 5, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc....

Previous 10 Next 10